Could Tocilizumab be an Attractive Therapeutic Option for Elderly Patients with Severe COVID-19? A Case Report

Detalles Bibliográficos
Autores principales: Streicher, Caroline, Engalenc, Xavier, Gaudin, Marion, Vignaud, Guillaume, Daulange, Annick, Abraham, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502217/
https://www.ncbi.nlm.nih.gov/pubmed/32951190
http://dx.doi.org/10.1007/s40261-020-00969-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502217/
https://www.ncbi.nlm.nih.gov/pubmed/32951190
http://dx.doi.org/10.1007/s40261-020-00969-5

Ejemplares similares